The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
Halneuron® treated patients separating from placebo on pain improvement assessment; Company expects top-line results ...
RedChip Companies will air interviews with Processa Pharmaceuticals, Inc. (Nasdaq:PCSA) and 60 Degrees Pharmaceuticals, Inc. ...
Written feedback from FDA pre-NDA meeting includes a recommendation to conduct a second Phase 3 trial to generate additional efficacy and safety data prior to NDA submission of brilaroxazine for the ...
The Malaysian Pineapple Industry Board (LPNM) will focus on strengthening the downstream pineapple industry in the 13th ...
According to sector experts, the decline in incentives for electric vehicles , coupled with the slow pace of charging ...
Motilal Oswal Alternates invests USD 72 million in Sensa Core Medical Instrumentation for a minority stake. Funds to boost ...
Nonclinical protocol study design accepted by FDA Study to commence in First Quarter 2026 King of Prussia, Pennsylvania–(Newsfile Corp. – December 23, 2025) – Phio Pharmaceuticals Corp. (NASDAQ: ...
Caliway has completed submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 2 clinical study of CBL-514 for weight management ...
Following a period of strong growth and increasing visibility across Ireland, INGLOT is entering a new phase of strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback